| Identification | Back Directory | [Name]
Pregn-5-en-3-ol,(3)-(9CI) | [CAS]
2862-58-0 | [Synonyms]
Δ5-Pregnen-3β-ol
3β-Hydroxypregn-5-ene
3beta-Hydroxypregn-5-ene
Pregn-5-en-3-ol,(3)-(9CI)
(3S,8S,9S,10R,13R,14S,17S)-17-ethyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol | [Molecular Formula]
C21H34O | [MOL File]
2862-58-0.mol | [Molecular Weight]
302.494 |
| Hazard Information | Back Directory | [Uses]
Pregn-5-en-3β-ol, a steroid compound, when formulated as the biscarboxylic acid hemiesters along with androst-5-en-3β-ol, serves as a potent positive allosteric modulator of NMDA (N-methyl-D-aspartate) receptors, making it applicable for research into psychiatric disorders[1]. | [Definition]
ChEBI: 3beta-Hydroxypregn-5-ene is a corticosteroid hormone. | [References]
[1] Marika Matousova, et al. Pregn-5-en-3β-ol and androst-5-en-3β-ol dicarboxylic acid esters as potential therapeutics for NMDA hypofunction: In vitro safety assessment and plasma stability. Steroids. 2019 Jul:147:4-9. DOI:10.1016/j.steroids.2018.09.012 |
|
| Company Name: |
Shureli Biopharma Co.,Ltd
|
| Tel: |
0871-68355600 18787766125 |
| Website: |
www.chemicalbook.com/showsupplierproductslist1143315/0.htm |
|